Case presentation icu

I need a bit more context to give you the most useful response. What type of ICU case presentation are you looking for?

Asking for Preferences

One more quick question to choose the right scenario:

Asking for Preferences

Great - building a teaching case on Sepsis / Septic Shock in the Medical ICU. Let me pull from the medical library and current guidelines simultaneously.

Reading File

Searching the Web

Surviving Sepsis Campaign 2024 guidelines management bundles

Now let me search the medical library for sepsis/septic shock content:

Finding Sources

Reading File

Finding Sources

Reading File

I now have excellent material from Harrison's and Goldman-Cecil. Let me compile the full teaching case presentation.

🏥 ICU Teaching Case Presentation: Septic Shock

PATIENT IDENTIFICATION


Name	Mr. A.K. (fictitious)
Age	67 years
Sex	Male
Weight	82 kg (IBW ~75 kg)
Admitted to	Medical ICU
Date	Day 1

CHIEF COMPLAINT

"Fever, confusion, and low blood pressure" for 12 hours.

HISTORY OF PRESENT ILLNESS

Mr. A.K. is a 67-year-old male with a history of type 2 diabetes, hypertension, and CKD stage 3 who presented to the emergency department with a 3-day history of dysuria and frequency, worsening to fever, chills, and altered mental status over the preceding 12 hours. His family reports he was increasingly confused and difficult to arouse at home. He has had no vomiting or diarrhea. No recent travel, sick contacts, or procedures.

On arrival to the ED:

T: 39.4°C, HR: 118 bpm, RR: 26/min, BP: 78/44 mmHg, SpO2: 91% on room air
Mental status: lethargic, GCS 11 (E3 V3 M5)

IV access was obtained, blood cultures x2 drawn, urinalysis sent, and 30 mL/kg (2,500 mL) of crystalloid initiated within 30 minutes. BP did not recover - patient was transferred to the MICU.

PAST MEDICAL HISTORY

Condition	Details
Type 2 Diabetes Mellitus	On metformin + sitagliptin; HbA1c 8.2% (3 months ago)
Hypertension	On amlodipine 10 mg
CKD Stage 3	Baseline Cr 1.6 mg/dL
BPH	On tamsulosin 0.4 mg

Surgical history: Appendectomy (age 22) Allergies: Penicillin (rash - no anaphylaxis documented) Social history: Retired schoolteacher, non-smoker, occasional alcohol Family history: Father died of MI; mother had DM

PHYSICAL EXAMINATION (on MICU arrival)

System	Findings
General	Lethargic, diaphoretic, flushed, ill-appearing
Vitals	T 39.6°C, HR 122, BP 82/50 (MAP 61), RR 28, SpO2 93% on 4L NC
HEENT	Dry mucous membranes; no meningismus
CVS	Tachycardia, regular rhythm; no murmurs; JVP low
Respiratory	Increased work of breathing; diffuse mild crackles bibasally
Abdomen	Soft, non-tender, no guarding
GU	Suprapubic tenderness; no CVA tenderness
Extremities	Warm, well-perfused peripherally (early distributive pattern)
Neuro	GCS 11, disoriented to time and place
Skin	No rash, no petechiae

INVESTIGATIONS

Labs on Admission

Test	Result	Reference
WBC	18,400/uL (86% neutrophils, 8% bands)	4,500-11,000
Hb	11.2 g/dL	13.5-17.5
Platelets	112,000/uL	150,000-400,000
Na	131 mEq/L	136-145
K	4.8 mEq/L	3.5-5.0
BUN	44 mg/dL	7-20
Creatinine	2.9 mg/dL	0.7-1.2 (baseline 1.6)
Glucose	322 mg/dL	70-99
Bilirubin (total)	1.9 mg/dL	0.2-1.2
ALT / AST	68 / 54 U/L	<40
Albumin	2.8 g/dL	3.5-5.0
Lactate	4.2 mmol/L	<2.0
Procalcitonin	18.4 ng/mL	<0.5
CRP	312 mg/L	<10
pH (ABG)	7.28	7.35-7.45
PaCO2	28 mmHg	35-45
PaO2	68 mmHg (on 4L NC)	80-100
HCO3	13 mEq/L	22-28
P/F ratio	~170	>300

Anion Gap: 131 - (101 + 13) = 17 (elevated; high-AG metabolic acidosis from lactate)

Urinalysis

WBC: >100/HPF, RBC: 5-10/HPF, nitrites: positive, leukocyte esterase: 3+, bacteria: many

Urine Culture: Pending

Blood Cultures x2: Pending

Chest X-ray

Mild bilateral lower lobe airspace opacities; no pneumothorax; no cardiomegaly

ECG

Sinus tachycardia at 120 bpm; no ischemic changes

Bedside Echocardiography (POCUS)

Hyperdynamic LV (EF ~65%), no significant pericardial effusion, IVC collapsible (volume responsive)

DIAGNOSIS

Primary Diagnosis:

Septic Shock (Sepsis-3 criteria)

Diagnostic criteria met:

Suspected infection (urosepsis)
Acute organ dysfunction: SOFA score 8 (see below)
Vasopressor requirement to maintain MAP ≥65 mmHg despite adequate fluid resuscitation
Serum lactate > 2 mmol/L (4.2 mmol/L) - not corrected by fluids

Sepsis-3 Definition (for teaching):

Sepsis = life-threatening organ dysfunction caused by dysregulated host response to infection. Operationalized by an acute change in total SOFA score ≥ 2.

Septic shock = subset of sepsis with vasopressor requirement to maintain MAP ≥ 65 mmHg AND serum lactate > 2 mmol/L despite adequate fluid resuscitation (hospital mortality >40%).

Harrison's Principles of Internal Medicine 22E, Chapter 315

SOFA Score Calculation

Organ	Parameter	Score
Respiratory (PaO2/FiO2 ~170)	170 = moderate impairment	2
Coagulation (Platelets 112k)	100-149	1
Liver (Bili 1.9)	1.2-1.9 = mild	1
Cardiovascular (MAP <65, on vasopressor)	Dopamine/NE use	2
CNS (GCS 11)	GCS 10-12	1
Renal (Cr 2.9)	2.0-3.4 mg/dL	1
TOTAL		8

(SOFA ≥ 2 = significant mortality risk; ≥ 11 = >50% mortality)

qSOFA (quick screening, not diagnostic):

Altered mentation: +1
RR ≥ 22: +1
SBP ≤ 100: +1
qSOFA = 3/3 (high risk, prompt ICU evaluation indicated)

DIFFERENTIAL DIAGNOSIS

Diagnosis	Against It
Cardiogenic shock	Hyperdynamic echo, low JVP, warm peripheries
Hypovolemic shock	Fever, leukocytosis, lactate very high; responds partially to fluids
Anaphylaxis	No urticaria, angioedema, or exposure history
Adrenal crisis	No hyperkalemia, eosinophilia; no prior steroid use
Acute pancreatitis	No abdominal pain, normal lipase
SIRS without infection	Urinalysis markedly abnormal; fever + leukocytosis with bands

(Differential based on Goldman-Cecil Medicine, Circulatory Therapy section)

MANAGEMENT PLAN

Immediate Priorities: "Hour-1 Bundle" (SSC 2021)

Element	Action in This Patient
1. Measure lactate	Done: 4.2 mmol/L - remeasure in 2h
2. Blood cultures x2	Done BEFORE antibiotics
3. Broad-spectrum antibiotics	Initiate within 1 hour (see below)
4. Crystalloid 30 mL/kg	In progress; 2.5L given
5. Vasopressor if MAP <65	Start norepinephrine

A. Hemodynamic Resuscitation

Fluids:

Complete 30 mL/kg isotonic crystalloid (balanced solution preferred: lactated Ringer's over NS to reduce hyperchloremic acidosis)
Reassess with POCUS after each 500 mL bolus (IVC collapsibility, lung B-lines)
Target: MAP ≥ 65 mmHg, UO ≥ 0.5 mL/kg/hr, lactate clearance ≥10% every 2h

"Early therapy is the cornerstone of emergency management, but such therapy need not achieve specific central hemodynamic or oxygen-delivery targets." (Goldman-Cecil Medicine, Treatment)

Vasopressors:

Norepinephrine (first-line) - start at 0.05-0.1 mcg/kg/min, titrate to MAP ≥ 65
If MAP remains low, add vasopressin 0.03 units/min as vasopressor-sparing agent
Avoid dopamine as first-line (higher mortality and arrhythmia risk vs. NE)
Consider dobutamine only if myocardial depression or low CO confirmed

"Norepinephrine is slightly, but not significantly, better than dopamine for reducing mortality when used as the first-line vasopressor for septic shock." (Goldman-Cecil Medicine)

Target MAP:

Standard: ≥ 65 mmHg (no benefit to higher targets in most patients)
Consider ≥ 70-80 mmHg in severe hypertension or known atherosclerosis

B. Antimicrobial Therapy

Source: Urinary tract (clinical + UA findings) Allergy: Penicillin (rash, not anaphylaxis) - proceed with caution; cross-reactivity low

Empiric Regimen	Rationale
Piperacillin-tazobactam 4.5g IV q8h (extended infusion)	Broad gram-negative coverage including Pseudomonas; risk of cross-reactivity with PCN rash is <2%
OR Ceftriaxone 2g IV q24h + metronidazole if PCN allergy concern	Avoids beta-lactam; narrower
Add vancomycin 25 mg/kg if MRSA risk (indwelling catheter, recent hospitalization)	Not indicated here initially

De-escalate within 48-72h based on culture sensitivities. Duration: 7-14 days for urosepsis with bacteremia (review per culture results).

Most common gram-negative organisms in US urosepsis: E. coli, Klebsiella spp., Pseudomonas aeruginosa. (Harrison's 22E, Chapter 315)

C. Respiratory Support

Currently SpO2 93% on 4L NC - inadequate
Escalate to high-flow nasal cannula (HFNC) at 40 L/min, FiO2 0.5
Target SpO2 ≥ 94%, PaO2 ≥ 70 mmHg
Monitor closely - P/F ratio 170 meets moderate ARDS criteria
Intubation criteria: RR >35, worsening hypoxemia (SpO2 <88% on HFNC), encephalopathy, hemodynamic collapse
If intubated: lung-protective ventilation - TV 6 mL/kg IBW (IBW = 75 kg → 450 mL), PEEP 8-12, FiO2 to target SpO2 88-95%

D. Source Control

Urine culture + sensitivity - expedite
Repeat urinalysis + urine Gram stain
Renal ultrasound - rule out obstructive uropathy (hydronephrosis, renal abscess) given BPH + urosepsis
If obstruction found - urgent urology consult for drainage
Remove any urinary catheter placed and replace with new sterile catheter; send urine from new catheter

E. Supportive Care

Intervention	Target/Details
Glycemic control	Glucose 140-180 mg/dL; insulin infusion protocol; hold metformin (AKI)
DVT prophylaxis	Enoxaparin 40 mg SC daily (renally dose-adjusted given Cr 2.9) OR UFH 5000u SC BID
Stress ulcer prophylaxis	Pantoprazole 40 mg IV daily (mechanically ventilated or coagulopathy)
Nutrition	Early enteral nutrition within 24-48h if hemodynamically stable; avoid TPN unless gut inaccessible
Steroids	Hydrocortisone 200 mg/day (continuous infusion or 50mg q6h) ONLY if refractory shock (NE >0.25 mcg/kg/min)
Sedation/Analgesia	If intubated: analgesia-first protocol; light sedation (RASS -1 to 0); daily awakening trials
Renal replacement	Not immediately - trend Cr, UO; CRRT if worsening AKI with volume overload, refractory acidosis, or K+ >6.5
Hold nephrotoxins	Metformin, NSAIDs, ACE inhibitors already held

MONITORING AND REASSESSMENT

Parameter	Frequency	Target
Vital signs, MAP	Continuous (arterial line)	MAP ≥ 65
Urine output	Hourly	≥ 0.5 mL/kg/hr
Lactate	Every 2h until normalized	Clearance ≥ 10% per 2h
Blood glucose	q1-2h while on insulin	140-180 mg/dL
Daily labs: CBC, BMP, LFTs, coags	q24h	Trend organ dysfunction
Blood cultures	24-48h if not clearing	Bacteremia clearance
Chest X-ray	Daily if intubated	ARDS progression
SOFA score	Daily	Track trajectory

DISCUSSION POINTS (for teaching)

1. Why Sepsis-3 matters: The 2016 Sepsis-3 definitions abandoned SIRS criteria (too sensitive, too non-specific) in favor of organ dysfunction (SOFA ≥2). This patient meets both sepsis AND septic shock (vasopressor + lactate >2 despite fluids). (Harrison's 22E, Chapter 315)

2. Lactate as a guide: Lactate of 4.2 mmol/L signals global tissue hypoperfusion. Serial lactate clearance (targeting >10% drop per 2 hours) is equivalent to and less invasive than ScvO2-guided therapy.

3. Why norepinephrine first? NE increases SVR without significant increase in heart rate. Dopamine's higher arrhythmia risk and no mortality benefit make it second-line. Vasopressin is added (not substituted) to reduce NE dose.

4. Antibiotic timing: Every hour of delay in antibiotic administration increases mortality by ~7%. Blood cultures must be obtained BEFORE antibiotics but must not delay antibiotic initiation beyond 1 hour.

5. The "ARDS complication" connection: P/F ratio 170 puts this patient in moderate ARDS territory. Sepsis is the most common cause of ARDS. Lung-protective ventilation (6 mL/kg IBW, plateau pressure <30 cmH2O) is mandatory if intubated.

6. Steroid controversy: Hydrocortisone is reserved for refractory septic shock (NE >0.25 mcg/kg/min). The ADRENAL trial (NEJM 2018) showed no 90-day mortality benefit but faster shock reversal and shorter ICU stay.

EXPECTED CLINICAL COURSE

Time	Expected if Responding
6h	Lactate trending down, MAP maintained on NE, mental status improving
24h	Culture results - de-escalate antibiotics
48-72h	Vasopressor weaning, fluid balance assessment (avoid fluid overload)
Day 3-5	Wean oxygen support; mobilize if stable
Day 7-10	Discharge from MICU to ward

PROGNOSIS

Hospital mortality for septic shock: ~30-40%
Key adverse prognostic features in this patient: Age >65, DM, CKD, AKI (Cr 2.9), lactate 4.2, P/F 170
SOFA 8 = estimated mortality ~20-30%; will reassess daily
Survivors are at risk for post-sepsis syndrome: cognitive impairment, fatigue, recurrent infections, muscle weakness for months

References: Harrison's Principles of Internal Medicine 22E (2025), Chapter 315; Goldman-Cecil Medicine, Circulatory Therapy; Surviving Sepsis Campaign 2021 Guidelines (SSC Hour-1 Bundle); WHO Sepsis Guidelines 2024

Explain this patient treatment very shortly

Mr. A.K. — Treatment Summary (Septic Shock from Urosepsis)

1. 🩸 Fluids

30 mL/kg crystalloid (2.5L given) to restore circulating volume
Use Lactated Ringer's (better than normal saline in sepsis)

2. 💉 Vasopressors

Norepinephrine (first-line) — to keep MAP ≥ 65 mmHg
Add vasopressin if NE dose gets high
Goal: adequate blood pressure + organ perfusion

3. 🦠 Antibiotics (within 1 hour)

Piperacillin-tazobactam (covers gram-negatives including Pseudomonas)
Blood cultures drawn before giving antibiotics
De-escalate in 48-72h once culture/sensitivity results return

4. 🫁 Oxygen

Escalate to high-flow nasal cannula
If worsening → intubate with lung-protective ventilation (6 mL/kg tidal volume)

5. 🔍 Source Control

Renal ultrasound to rule out obstruction (he has BPH)
Replace urinary catheter
Treat the underlying UTI as the primary source

6. 🛡️ Supportive Care

What	Why
Insulin infusion	Glucose 140-180 mg/dL
Hold metformin	AKI present
DVT prophylaxis	Immobile ICU patient
Stress ulcer cover	Pantoprazole
Steroids (hydrocortisone)	Only if shock remains refractory to NE

The Core Principle:

Kill the bug. Support the circulation. Protect the organs. Don't over-resuscitate.

Reassess lactate every 2 hours - if it's clearing (dropping >10%), the patient is responding.

More explain

Here is a detailed explanation of each treatment step for Mr. A.K., written clearly for teaching purposes.

Mr. A.K. — Full Treatment Explanation

Septic Shock Secondary to Urosepsis

1. FLUID RESUSCITATION

What was given?

30 mL/kg isotonic crystalloid = ~2,500 mL of Lactated Ringer's (LR) given rapidly over the first 1-3 hours.

Why fluids?

In septic shock, bacteria and their toxins cause massive vasodilation + capillary leak. This means:

Blood vessels dilate → effective circulating volume drops
Fluid leaks out of vessels into tissues → further reducing preload
The heart has less blood to pump → cardiac output falls → organs get less oxygen

Giving IV fluids restores preload (fills the tank), which increases cardiac output and improves organ perfusion.

Why Lactated Ringer's instead of Normal Saline?

	Normal Saline (0.9% NaCl)	Lactated Ringer's
Chloride content	Very high (154 mEq/L)	Physiologic (109 mEq/L)
Risk	Hyperchloremic metabolic acidosis	Lower
Preferred in sepsis?	No	Yes

This patient already has metabolic acidosis (pH 7.28, HCO3 13) - using NS would worsen it.

When to STOP fluids?

Fluids are not unlimited. Over-resuscitation causes:

Pulmonary edema (worsens ARDS)
Abdominal compartment syndrome
Prolonged ICU stay

Stop and reassess after each 500 mL bolus using:

POCUS: Is IVC collapsible? (means volume responsive)
Lung ultrasound: Are B-lines (fluid) appearing?
Urine output: Is it improving?
Lactate: Is it clearing?

2. VASOPRESSORS

What is given?

Norepinephrine (NE) - started at 0.05-0.1 mcg/kg/min via central line, titrated up to keep MAP ≥ 65 mmHg.

Why is MAP ≥ 65 the target?

MAP drives blood into organs (perfusion pressure). Below 65 mmHg:

Kidneys stop filtering (AKI worsens)
Brain under-perfuses (confusion/coma)
Gut mucosa ischemia → bacterial translocation → worsens sepsis

Why Norepinephrine (not dopamine)?

Drug	Mechanism	Problem
Norepinephrine	Alpha-1 (vasoconstriction) + mild Beta-1	First choice - fewer arrhythmias
Dopamine	Alpha + Beta + Dopaminergic	More tachycardia, more arrhythmias, higher mortality
Vasopressin	V1 receptor vasoconstriction	Added as 2nd agent to spare NE dose
Dobutamine	Beta-1 (inotrope)	Add ONLY if low cardiac output confirmed

How does norepinephrine work in sepsis?

Sepsis causes extreme vasodilation (distributive shock). NE squeezes peripheral vessels (raises SVR), redirecting blood to vital organs. It does NOT primarily speed up the heart - this is why it is safe in tachycardic patients.

When to add vasopressin?

If NE dose exceeds 0.25 mcg/kg/min, add vasopressin 0.03 units/min. It works via a different receptor (V1), allowing NE dose reduction.

When to add steroids?

If despite NE + vasopressin, MAP is still below 65 → relative adrenal insufficiency may be present.

Give hydrocortisone 200 mg/day (50 mg IV q6h or continuous infusion)
Does NOT reduce mortality, but speeds shock reversal and gets patient off vasopressors faster

3. ANTIBIOTICS

The golden rule: Blood cultures FIRST, antibiotics within 1 hour

Every 1-hour delay in antibiotics = ~7% increase in mortality.

Why blood cultures before antibiotics?

Once antibiotics are given, bacteria are killed rapidly → cultures become negative. Blood cultures identify the exact organism and its sensitivities, allowing you to de-escalate from broad to targeted therapy later.

What was chosen and why?

Piperacillin-tazobactam (Pip-tazo) 4.5g IV q8h (extended infusion over 4h)

Reason	Explanation
Gram-negative coverage	Covers E. coli, Klebsiella (most common urosepsis bugs)
Pseudomonas coverage	Important in ICU/septic shock patients
Beta-lactamase inhibitor	Tazobactam protects piperacillin from resistance enzymes
Extended infusion	Keeps drug level above MIC for longer → better kill for time-dependent antibiotics

What about the penicillin allergy?

He has a rash (not anaphylaxis)
Cross-reactivity between penicillin and pip-tazo is <2%
In life-threatening septic shock, the benefit outweighs the low risk
If true anaphylaxis: use aztreonam + metronidazole or a carbapenem

When to de-escalate?

At 48-72 hours, when culture and sensitivity results return
If E. coli sensitive to ceftriaxone → step down to ceftriaxone (narrower, cheaper, less resistance pressure)
Duration: 7-14 days for urosepsis with bacteremia

4. RESPIRATORY SUPPORT

Current status:

SpO2 93% on 4L nasal cannula → inadequate
P/F ratio = 170 → moderate ARDS

Step 1: High-Flow Nasal Cannula (HFNC)

Flow rate: 40-60 L/min, FiO2 0.5
Delivers heated, humidified oxygen at high flow
Creates mild PEEP effect → opens collapsed alveoli
Reduces work of breathing without intubation
Target: SpO2 ≥ 94%

Step 2: Intubation (if HFNC fails)

Indications to intubate:

RR > 35 breaths/min
SpO2 < 88% despite HFNC
Worsening confusion (cannot protect airway)
Hemodynamic collapse

If intubated - Lung Protective Ventilation:

Parameter	Target	Why
Tidal Volume	6 mL/kg IBW (= 450 mL)	Prevents ventilator-induced lung injury (VILI)
Plateau Pressure	< 30 cmH2O	Prevents barotrauma
PEEP	8-12 cmH2O	Keeps alveoli open, improves oxygenation
FiO2	Titrate to SpO2 88-95%	Avoid hyperoxia (also harmful)
RR	16-20/min	Compensate for metabolic acidosis

The ARMA trial proved 6 mL/kg tidal volume reduces ARDS mortality by 22% compared to conventional 12 mL/kg.

5. SOURCE CONTROL

Why is this step critical?

Antibiotics alone cannot cure sepsis if the source is not controlled. Think of it like: antibiotics kill the bacteria in the bloodstream, but if bacteria keep pouring in from an obstructed kidney, the battle is lost.

Actions for this patient:

a) Renal Ultrasound (urgent)

This patient has BPH (enlarged prostate)
BPH can cause urinary obstruction → urine backs up into kidney (hydronephrosis)
Obstructed, infected urine = pyonephrosis - bacteria multiply in a sealed space, antibiotics cannot penetrate well
If obstruction found → urgent urology consult for nephrostomy tube or ureteral stent

b) Replace urinary catheter

Insert a new sterile Foley catheter (decompresses bladder)
Allows hourly urine output monitoring (critical in ICU)
Send urine from the new catheter for culture

c) Serial urine cultures

Identify exact pathogen + sensitivities
Guide antibiotic de-escalation

6. SUPPORTIVE CARE - DETAILED

A. Glycemic Control

Patient's glucose: 322 mg/dL (severely elevated)
Hyperglycemia in ICU causes:
- Impaired neutrophil function (worsens infection)
- Increased mortality
- Worsens AKI
Start insulin infusion, target glucose 140-180 mg/dL
AVOID tight control (<110) - causes dangerous hypoglycemia (NICE-SUGAR trial)
Hold metformin - causes lactic acidosis in AKI

B. Acute Kidney Injury Management

Baseline Cr: 1.6 → Now: 2.9 mg/dL (Stage 2 AKI by KDIGO)
Causes in this patient:
1. Sepsis-induced renal vasodilation and hypoperfusion
2. Direct endotoxin injury to tubular cells
3. Possible obstruction (BPH)
Management:
- Restore MAP ≥ 65 (NE + fluids)
- Relieve obstruction (ultrasound + catheter)
- Avoid nephrotoxins: NSAIDs, aminoglycosides, IV contrast
- Renally dose ALL medications (antibiotics, LMWH)
- Monitor urine output hourly
- Consider CRRT (continuous renal replacement) if:
  - Refractory volume overload
  - K+ > 6.5 mEq/L
  - pH < 7.1 despite treatment

C. DVT Prophylaxis

ICU patients are at very high VTE risk (immobile, inflamed, hypercoagulable)
Give enoxaparin 30 mg SC daily (dose-reduced for CrCl ~25 mL/min)
OR unfractionated heparin 5000u SC q8-12h if eGFR very low
Add pneumatic compression devices (SCDs) to both legs

D. Stress Ulcer Prophylaxis

Critically ill patients develop stress ulcers (erosive gastritis) due to mucosal ischemia
Risk factors: mechanical ventilation, coagulopathy (platelets 112k here)
Give pantoprazole 40 mg IV daily
Not needed once patient is eating/drinking

E. Nutrition

Start early enteral nutrition (EN) within 24-48 hours once hemodynamically stable
Use nasogastric tube if patient cannot eat
EN (gut feeding) maintains gut mucosal integrity, prevents bacterial translocation, supports immunity
Avoid TPN (parenteral nutrition) unless gut is not accessible - higher infection risk, worsens hyperglycemia

F. Sedation and Analgesia (if intubated)

Principle	Detail
Analgesia first	Treat pain before sedation (fentanyl infusion)
Light sedation	Target RASS -1 to 0 (arousable)
Daily awakening trial	Stop sedation daily, assess if patient can be weaned
Avoid benzodiazepines	Use propofol or dexmedetomidine - less delirium
Delirium monitoring	Use CAM-ICU scale twice daily

7. MONITORING - WHAT WE WATCH AND WHY

What	How Often	Target	Why
MAP (arterial line)	Continuous	≥ 65 mmHg	Organ perfusion
Urine output (Foley)	Hourly	≥ 0.5 mL/kg/hr	Kidney perfusion marker
Lactate	Every 2 hours	Clearance >10%/2h	Confirms tissue perfusion improving
Blood glucose	Every 1-2h on insulin	140-180 mg/dL	Avoid hypo/hyperglycemia
SOFA score	Daily	Decreasing trend	Overall organ function
Blood cultures	24-48h after first set	Negative	Confirm bacteremia cleared
Daily CXR	Daily (if ventilated)	No worsening ARDS	Track lung status
Creatinine, electrolytes	Every 12-24h	Trending down	AKI recovery

8. THE BIG PICTURE - HOW IT ALL CONNECTS

INFECTION (UTI/Urosepsis)
        ↓
Bacteria enter bloodstream → BACTEREMIA
        ↓
Immune system overreacts → cytokine storm
        ↓
Vasodilation + Capillary Leak
        ↓
↓ BP + ↓ Organ Perfusion
        ↓
    [SEPTIC SHOCK]
        ↓
  ┌─────────────────────────────────┐
  │  Fluids → restore preload       │
  │  NE → restore vascular tone     │  ← SIMULTANEOUSLY
  │  Antibiotics → kill the bug     │
  │  Source control → stop the leak │
  └─────────────────────────────────┘
        ↓
  Organ support while body recovers
  (Ventilator, Insulin, RRT if needed)
        ↓
   Wean vasopressors → Wean vent
        → Discharge from ICU

9. EXPECTED TRAJECTORY

Day	If Responding Well
Day 1	Lactate falling, MAP on low-dose NE, mental status improving
Day 2	Culture results back, de-escalate antibiotics, reducing NE
Day 3	Vasopressor weaned off, oxygen requirements decreasing
Day 5	Off HFNC/ventilator, tolerating oral intake
Day 7-10	Transfer to general ward, oral antibiotics
Day 14	Discharge home

Key Teaching Point: Septic shock is a race against time. The three non-negotiables are: antibiotics within 1 hour, MAP ≥ 65 with vasopressors, and source control. Everything else is supportive while the body recovers. (Surviving Sepsis Campaign 2021; Harrison's Principles 22E)

Haemoorrhage types in short

Types of Haemorrhage — Quick Reference

1. BY VESSEL TYPE

Type	Source	Appearance
Arterial	Artery	Bright red, spurting, pulsatile — most dangerous
Venous	Vein	Dark red, steady flow, oozing
Capillary	Capillaries	Slow ooze, often self-limiting

2. BY LOCATION

Type	Definition	Example
External	Blood exits the body	Wound, epistaxis, haematemesis
Internal	Blood stays inside body cavities	Haemothorax, haemoperitoneum
Concealed	Hidden within tissues	Haematoma, retroperitoneal bleed

3. BY ANATOMICAL SITE

Site	Name	Key Feature
Brain (outside dura)	Epidural haematoma	Arterial (middle meningeal a.), lucid interval
Brain (under dura)	Subdural haematoma	Venous, crescent-shaped on CT
Brain (subarachnoid)	Subarachnoid haemorrhage	"Worst headache of life", berry aneurysm
Brain tissue itself	Intracerebral haemorrhage	HTN commonest cause
Chest	Haemothorax	Trauma, dullness on percussion
Abdomen	Haemoperitoneum	Trauma, ruptured spleen/liver
GI tract (upper)	Haematemesis / Melaena	Above ligament of Treitz
GI tract (lower)	Haematochezia	Fresh blood PR, colonic source
Lungs	Haemoptysis	Blood coughed up
Joints	Haemarthrosis	Haemophilia, trauma
Retroperitoneum	Retroperitoneal bleed	AAA rupture, pelvic fracture

4. BY SEVERITY — TRAUMA CLASS (ATLS)

Class	Blood Loss	Volume Lost	HR	BP	RR	Mental Status
Class I	Up to 15%	<750 mL	<100	Normal	14-20	Normal
Class II	15-30%	750-1500 mL	100-120	Normal	20-30	Anxious
Class III	30-40%	1500-2000 mL	120-140	↓	30-40	Confused
Class IV	>40%	>2000 mL	>140	Very ↓	>35	Lethargic/Unconscious

Class III and IV = immediate intervention (blood transfusion, surgery)

5. BY TIMING (SURGICAL CONTEXT)

Type	When	Cause
Primary	At time of injury/surgery	Direct vessel damage
Reactionary	Within 24h post-op	Clot dislodgement, BP rises
Secondary	7-14 days post-op	Infection eroding vessel wall

6. BY ONSET

Type	Description
Acute	Sudden, rapid blood loss (trauma, rupture)
Chronic	Slow ongoing loss (peptic ulcer, colorectal cancer) → presents as anaemia

QUICK MEMORY AID

HAEMORRHAGE = WHERE + HOW MUCH + HOW FAST

WHERE  → vessel type + anatomical site
HOW MUCH → ATLS Class I–IV
HOW FAST → Acute vs Chronic

Most immediately life-threatening haemorrhages: Epidural haematoma | Aortic rupture | Haemothorax | Haemoperitoneum | PPH

This is a shared conversation. Sign in to Orris to start your own chat.